Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Revenue

Marksans Pharma had revenue of 9.40B INR in the quarter ending September 30, 2026, with 30.50% growth. This brings the company's total for the last twelve months to 33.92B, up 24.20% year-over-year. In the fiscal year ending March 31, 2026, Marksans Pharma had annual revenue of 29.51B with 12.51% growth. That makes Marksans Pharma the 13,264th largest company in the world by revenue and 655th in India.

• Revenue (ttm): 33.92B
• Revenue Growth: +24.20%
• P/S Ratio: 4.06
• Revenue / Employee: 20.13M
• Employees: 1,685
• Market Cap: 139.67B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States and North America 15.33B 52.0%
• Europe and The United Kingdom 10.15B 34.4%
• Australia and New Zealand 3.03B 10.3%
• Rest of World 994.34M 3.4%

Fiscal year ended Mar 31, 2026 See the full Marksans Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	29.51B	3.28B	12.51%
Mar 31, 2025	26.23B	4.45B	20.46%
Mar 31, 2024	21.77B	3.25B	17.56%
Mar 31, 2023	18.52B	3.61B	24.23%
Mar 31, 2022	14.91B	1.15B	8.33%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error